Correlation of Plasma Copeptin and Vasopressin Concentrations in Hypo-, Iso-, and Hyperosmolar States
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Background: Copeptin, the C-terminal moiety of provasopressin, is cosecreted with vasopressin. Copeptin may be a useful parameter to characterize disorders of water homeostasis and can be readily measured in plasma or serum. However, it is unknown to date how circulating copeptin and vasopressin levels correlate at different plasma osmolalites. Objective: To correlate plasma copeptin with plasma osmolality and vasopressin concentrations in healthy subjects during iso-, hypo-, and hyperosmolar states. Methods: Plasma osmolalities, copeptin, and vasopressin levels were measured in 20 volunteers at baseline, after an oral water load, and during and after iv infusion of 3% saline. Correlation coefficients were determined between plasma osmolalites and copeptin and vasopressin concentrations, as well as between vasopressin and copeptin concentrations. Results: Median plasma osmolalities decreased from 290 mOsm/kg (range, 284–302) at baseline to 281 (273–288) mOsm/kg after water load and rose to 301 (298–307) mOsm/kg after hypertonic saline. Median plasma copeptin concentrations decreased from 3.3 (1.1–36.4) pm at baseline to 2.0 (0.9–10.4) pm after water load and increased to 13.6 (3.7–43.3) pm after hypertonic saline. Vasopressin and copeptin concentrations correlated with plasma osmolality (Spearman's rank correlation coefficient 0.49 and 0.77, respectively). There was a close correlation of vasopressin and copeptin concentrations (Spearman's rank correlation coefficient 0.8). Conclusion: Plasma vasopressin and copeptin correlate strongly over a wide range of osmolalities in healthy individuals. Therefore, the measurement of copeptin, which remains stable for several days, is a useful alternative to vasopressin measurements and will likely facilitate the differential diagnosis of disorders of water metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A strong correlation between plasma AVP (when measured with a well-established radio-immunoassay) and copeptin levels has been demonstrated in healthy volunteers (184), and, therefore, copeptin measurement could be an alternative marker to elucidate the effects of opioids on AVP.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [184]
Citations
Cites
Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin
Morgenthaler, N. G., Struck, J., Alonso, C., & Bergmann, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.060038 · Cited by 1,166
Self-citationRobertson, G. L., Mahr, E. A., Athar, S., & Sinha, T. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107423 · Cited by 787
Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor
Land, H., Schütz, G., Schmale, H., & Richter, D. (1982) · Nature · doi:10.1038/295299a0 · Cited by 569 · cited 1×
“AVP is synthesized as prepro-hormone and consists of a signal peptide, the AVP and neurophysin II moieties, and a C-terminal peptide of 39 amino acids, termed copeptin, that contains a single N-linked glycosylation site (5, 6) (Fig.”
BackgroundOsmotic and nonosmotic control of vasopressin release
Schrier, R. W., Berl, T., & Anderson, R. J. (1979) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1979.236.4.f321 · Cited by 502
Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction
Reichlin, T., Hochholzer, W., Stelzig, C., Laule, K., Freidank, H., Morgenthaler, N. G., Bergmann, A., Potocki, M., Noveanu, M., Breidthardt, T., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.076 · Cited by 434
Self-citationCopeptin: clinical use of a new biomarker
Morgenthaler, N. G., Struck, J., Jochberger, S., & Dünser, M. W. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.11.001 · Cited by 408
Self-citationKhan, S. Q., Dhillon, O. S., O’Brien, R. J., Struck, J., Quinn, P. A., Morgenthaler, N. G., Squire, I. B., Davies, J. E., Bergmann, A., & Ng, L. L. (2007) · Circulation · doi:10.1161/circulationaha.106.685503 · Cited by 353
Self-citationSausville, E., Carney, D., & Battey, J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39236-0 · Cited by 338
Copeptin Improves Early Diagnosis of Acute Myocardial Infarction
Keller, T., Tzikas, S., Zeller, T., Czyz, E., Lillpopp, L., Ojeda, F. M., Roth, A., Bickel, C., Baldus, S., Sinning, C. R., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.029 · Cited by 336
Copeptin and Arginine Vasopressin Concentrations in Critically Ill Patients
Jochberger, S., Morgenthaler, N. G., Mayr, V. D., Luckner, G., Wenzel, V., Ulmer, H., Schwarz, S., Hasibeder, W. R., Friesenecker, B. E., & Dünser, M. W. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2830 · Cited by 271
Self-citationStolz, D., Christ-Crain, M., Morgenthaler, N. G., Leuppi, J., Miedinger, D., Bingisser, R., Müller, C., Struck, J., Müller, B., & Tamm, M. (2007) · Chest · doi:10.1378/chest.06-2336 · Cited by 270
Self-citationMorgenthaler, N. G., Müller, B., Struck, J., Bergmann, A., Redl, H., & Christ-Crain, M. (2007) · Shock · doi:10.1097/shk.0b013e318033e5da · Cited by 268
Self-citationCopeptin: A novel, independent prognostic marker in patients with ischemic stroke
Katan, M., Fluri, F., Morgenthaler, N. G., Schuetz, P., Zweifel, C., Bingisser, R., Müller, K., Meckel, S., Gass, A., Kappos, L., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21783 · Cited by 267
Self-citationStruck, J., Morgenthaler, N. G., & Bergmann, A. (2005) · Peptides · doi:10.1016/j.peptides.2005.04.019 · Cited by 240
Self-citationNeuhold, S., Huelsmann, M., Strunk, G., Stoiser, B., Struck, J., Morgenthaler, N. G., Bergmann, A., Moertl, D., Berger, R., & Pacher, R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.050 · Cited by 236
Self-citationCopeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure
Stoiser, B., Mörtl, D., Hülsmann, M., Berger, R., Struck, J., Morgenthaler, N. G., Bergmann, A., & Pacher, R. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01724.x · Cited by 226
Self-citationSzinnai, G., Morgenthaler, N. G., Berneis, K., Struck, J., Müller, B., Keller, U., & Christ-Crain, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0232 · Cited by 224
Self-citationCopeptin in the Differential Diagnosis of Hyponatremia
Fenske, W., Störk, S., Blechschmidt, A., Maier, S. G. K., Morgenthaler, N. G., & Allolio, B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1426 · Cited by 212
Self-citationRobertson, G. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70207-3 · Cited by 209
Regulation of Arginine Vasopressin in the Syndrome of Inappropriate Antidiuresis
Robertson, G. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.006 · Cited by 203
Selected Contribution: Sex differences in osmotic regulation of AVP and renal sodium handling
Stachenfeld, N. S., Splenser, A. E., Calzone, W. L., Taylor, M. P., & Keefe, D. L. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.4.1893 · Cited by 189 · cited 1×
“All female subjects were investigated during the follicular phase of the menstrual cycle, when the osmotic threshold for AVP release is similar in men and women (29).”
Distribution, blood transport, and degradation of antidiuretic hormone in man.
Baumann, G., & Dingman, J. F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108377 · Cited by 172
Effect of water deprivation on cognitive-motor performance in healthy men and women
Szinnai, G., Schachinger, H., Arnaud, M. J., Linder, L., & Keller, U. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00501.2004 · Cited by 150
Kelly, D., Squire, I. B., Khan, S. Q., Quinn, P. A., Struck, J., Morgenthaler, N. G., Davies, J. E., & Ng, L. L. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.07.231 · Cited by 141
Self-citationKluge, M., Riedl, S., Erhart-Hofmann, B., Hartmann, J., & Waldhauser, F. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.1.98 · Cited by 90
Katan, M., Morgenthaler, N. G., Dixit, K. C. S., Rutishauser, J., Brabant, G. E., Müller, B., & Christ-Crain, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2046 · Cited by 85
Self-citationZerbe, R. L., Miller, J. Z., & Robertson, G. L. (1991) · PubMed · Cited by 83
Disorders of Water and Salt Metabolism Associated with Pituitary Disease
Loh, J. A., & Verbalis, J. G. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.008 · Cited by 75
PLASMA-ARGININE-VASOPRESSIN RESPONSE TO INSULIN-INDUCED HYPOGLYCÆMIA
Baylis, P. H., & Heath, D. A. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90610-9 · Cited by 64
ENDOGENOUS VASOPRESSIN AND COPEPTIN RESPONSE IN MULTIPLE TRAUMA PATIENTS
Westermann, I., Dünser, M. W., Haas, T., Jochberger, S., Luckner, G., Mayr, V. D., Wenzel, V., Stadlbauer, K., Innerhofer, P., Morgenthaler, N. G., et al. (2007) · Shock · doi:10.1097/shk.0b013e3180cab33f · Cited by 63
Self-citationMasiá, M., Papassotiriou, J., Morgenthaler, N. G., Hernández‐Aguado, I., Shum, C., & Gutiérrez, F. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.085688 · Cited by 54
Self-citationThe use of vasopressin assays in physiology and pathophysiology.
Gl, R. (1994) · PubMed · Cited by 53
Kleindienst, A., Brabant, G., Morgenthaler, N. G., Dixit, K. C., Parsch, H., & Buchfelder, M. (2010) · Acta Neurochirurgica Supplementum · doi:10.1007/978-3-211-98811-4_41 · Cited by 40
Self-citation
Cited by
Disorders of Plasma Sodium — Causes, Consequences, and Correction
Sterns, R. H. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1404489 · Cited by 634
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus
Fenske, W., Refardt, J., Chifu, I., Schnyder, I., Winzeler, B., Drummond, J., Ribeiro-Oliveira, A., Drescher, T., Bilz, S., Vogt, D. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1803760 · Cited by 310
Vasopressin: physiology, assessment and osmosensation
Bankir, L., Bichet, D. G., & Morgenthaler, N. G. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12645 · Cited by 266
Self-citationMeasuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers
Leng, G., & Sabatier, N. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12413 · Cited by 237
Water Intake, Water Balance, and the Elusive Daily Water Requirement
Armstrong, L. E., & Johnson, E. C. (2018) · Nutrients · doi:10.3390/nu10121928 · Cited by 235
Metadata
- Authors
- Balanescu, S., Kopp, P., Gaskill, M. B., Morgenthaler, N. G., Schindler, C., & Rutishauser, J.
- Affiliations
- Spitalzentrum Centre hospitalier Biel- Bienne (CH)
- Northwestern University (US)
- Thermo Fisher Scientific (Germany) (DE)
- University of Basel (CH)
- Corresponding author
- Rutishauser, Jonas
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-04-01
- Volume
- 96
- Issue
- 4
- Pages
- 1046-1052
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1991337124
- Semantic Scholar
- 844c5958060267f48000cd5026591990d577e9c1
- Cited by
- 246
- References
- 33
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 22 · 2023: 23 · 2022: 19 · 2021: 23 · 2020: 23 · 2019: 16 · 2018: 19 · 2017: 19 · 2016: 26 · 2015: 12 · 2014: 13 · 2013: 9 · 2012: 3
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion)
- edoc (University of Basel)
- Topics
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- copeptin, vasopressin, plasma osmolality, water homeostasis, hypoosmolarity, hyperosmolarity, water load, hypertonic saline infusion
- MeSH terms
- Adult, Female, Glycopeptides, Health Status, Humans, Hypotonic Solutions, Male, Osmolar Concentration, Saline Solution, Hypertonic, Vasopressins, Water, Water-Electrolyte Balance, Water-Electrolyte Imbalance, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.